Observing the quality of life in patients with benign prostatic hyperplasia
Official title: Studio Osservazionale Sulla qualità di Vita di Pazienti Affetti da IPB in Terapia Medica e/o Sottoposti a Intervento Chirurgico
Run by IRCCS San Raffaele · NCT06182189 · Data updated 2026-11-12
This study looks at how different treatments for benign prostatic hyperplasia affect the daily lives and well-being of patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 8000 (estimated) |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 1 site (Milan, Lombardy) |
| Status | Recruiting |
| Started | December 1, 2014 |
| Main results expected | December 31, 2024 |
| Study ends | December 31, 2034 |
| Registry record updated | December 26, 2023 |
| Trial ID | NCT06182189 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who are experiencing benign prostatic hyperplasia and are either on medical therapy or scheduled for surgery.
✕Probably not a fit
Patients under 18 years old or those with mental or physical disabilities that hinder their ability to complete questionnaires will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on assessing the quality of life of patients diagnosed with benign prostatic hyperplasia (BPH) who are either receiving medical therapy or undergoing surgical procedures. Data will be collected through a specially designed database that captures various clinical conditions, psychological factors, and overall quality of life metrics. The study aims to provide insights into how these treatments affect patients' daily lives and well-being over time.
Why it matters
Potential benefit: If successful, this study could enhance understanding of how BPH treatments impact patients' quality of life, leading to improved management strategies.
How similar studies have gone: While observational studies on quality of life in BPH patients exist, this specific approach focusing on a comprehensive database for statistical analysis may offer novel insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * subjects suffering from benign prostatic hyperplasia undergoing medical therapy and/or undergoing surgery * subjects \>= 18 years old * signature of informed consent Exclusion Criteria: * subjects \< 18 years * presence of mental or physical disability that may prevent the patient from answering the questionnaires.
Where it's running
-
IRCCS Ospedale San Raffaele
Milan, Lombardy, Italy Recruiting
Study contacts
- Principal investigator: Andrea Salonia, MD — IRCCS Ospedale San Raffaele
- Study coordinator: Andrea Salonia, MD
- Email: salonia.andrea@hsr.it
- Phone: 02 2643 5661
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sonablate HIFU Registry for Prostate Cancer and BPH
This registry collects real-world data from men treated with Sonablate HIFU to see how well it works and how it affects urinary and sexual function over the long term.
-
Tamsulosin alone vs. tamsulosin with tadalafil for troublesome urinary symptoms from enlarged prostate
This study tests whether adding tadalafil to tamsulosin helps men with BPH see better urinary symptoms and quality of life, using two tadalafil doses over 12 weeks.
-
MRI-DTI look at the urethral sphincter ring and prostate base shape
This imaging study tests how the male urethral internal sphincter ring appears on MRI-DTI and how it relates to prostate base morphology in men undergoing clinically indicated MRI.
-
Tamsulosin With or Without Tadalafil for a Trial Without Catheter After Acute Urinary Retention
This study tests whether adding tadalafil to tamsulosin helps men with a first episode of acute urinary retention due to enlarged prostate pass urine without needing a catheter.
-
Tamsulosin dose change or switch to silodosin before catheter removal in men with BPH-related acute urinary retention
This trial tests whether continuing tamsulosin, increasing its dose, or switching to silodosin helps men with BPH-related acute urinary retention go without a catheter after seven days.
-
Water Vapor Therapy vs Ejaculation-Sparing Enucleation for Benign Prostatic Hyperplasia
This study tests whether Water Vapor Thermal Therapy (Rezum) or an ejaculation-sparing enucleation procedure better helps sexually active men with bothersome BPH symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.